SINO BIOPHARMACEUTICAL LTD earnings per share and revenue

SMZ1 earnings per share for the last semiannual are 0.01 EUR whereas the estimation was 0.01 EUR which accounts for 9.43% surprise. Company revenue for the same period amounts to 2.04 B EUR despite the estimated figure of 1.95 B EUR. Estimated earnings per share for the next semiannual are 0.01 EUR, and revenue is expected to reach 1.99 B EUR. Also watch annual changes over time to get a bigger picture of SMZ1 earnings per share and revenue dynamics.